Utilisation of Next Generation Imaging Modalities and Novel Valve Technology in Transcatheter Aortic Valve Implantation (Tavi)

This webinar is designed to showcase cutting edge technologies being employed by operators during Transcatheter Aortic Valve Implantation at the Charité – Universitätsmedizin, Berlin, Germany.

Imaging

Percutaneous interventions in structural heart diseases are evolving rapidly. The variety of novel percutaneous treatment approaches and the increasing complexity of interventional procedures are associated with new challenges and demands on the imaging specialist. Standard catheterisation laboratory imaging modalities such as fluoroscopy and contrast ventriculography provide inadequate visualisation of the soft tissue or three-dimensional delineation of the heart.

Consequently, novel hybrid imaging modalities such as HeartNavigator are being employed by expert centres to ensure insightful planning and guidance of their structural heart procedures. HeartNavigator is an interventional planning and live guidance tool providing physicians the insight to quickly increase their confidence in performing SHD procedures. Originally developed for TAVI, it has developed into a comprehensive multipurpose solution:

• Deeper anatomical understanding to plan and perform TAVI, TMVR, and LAAO procedures
• Immersive user experience and fully automated tasks (TAVI) simplify planning, measurement, device selection, and choice of optimal X-ray viewing angle.

Valve Selection

Aortic valve replacement (AVR) has been the mainstay of treatment of symptomatic severe aortic stenosis (AS). The role of transcatheter aortic valve implantation (TAVI ) as an alternative to surgical aortic valve replacement (SAVR) is established in any patient subsets and evolving in other younger patients as data emerges. For the majority of patients undergoing TAVI, one of the latest generation devices are generally suitable but factors such as patient-specific issues and operator experience may influence valve selection. At the Charité–Universitätsmedizin, Berlin, Germany they regularly use the Portico™ valve to maximise outcomes for their patients.

The Portico™

Transcatheter Aortic Heart Valve offers outstanding control and accuracy for optimal patient outcomes with low rates of post-procedure pacemaker implantations, complications and paravalvular leak (PVL). The valve’s unique delivery system provides controlled deployment for greater accuracy and precise placement.